Neurodiagnostics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Neurodiagnostics Market
1.1. Definition and Scope
1.1.1. Definition of Neurodiagnostics
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Neurodiagnostics Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Neurodiagnostics Market By Product
1.2.3. Neurodiagnostics Market By Condition
1.2.4. Neurodiagnostics Market By End-Use
1.2.5. Neurodiagnostics Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Neurodiagnostics Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Neurodiagnostics Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Others Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Others Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Neurodiagnostics Market By Condition
5.1. Introduction
5.2. Neurodiagnostics Revenue By Product
5.2.1. Neurodiagnostics Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Diagnostic & Imaging Systems
5.2.2.1. Diagnostic & Imaging Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Electroencephalogram (EEG) Systems
5.2.2.2.1. Electroencephalogram (EEG) Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Magnetic Resonance Imaging (MRI) Systems
5.2.2.3.1. Magnetic Resonance Imaging (MRI) Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.4. Ultrasound Imaging Systems
5.2.2.4.1. Ultrasound Imaging Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.5. Computed Tomography (CT) Scanner
5.2.2.5.1. Computed Tomography (CT) Scanner Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.6. Others
5.2.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. In-vitro diagnostics (IVD)
5.2.3.1. In-vitro diagnostics (IVD) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Molecular Diagnostics
5.2.3.2.1. Molecular Diagnostics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Other IVDs
5.2.3.3.1. Other IVDs Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Neurodiagnostics Market By Condition
6.1. Introduction
6.2. Neurodiagnostics Revenue By Condition
6.2.1. Neurodiagnostics Revenue (USD Billion) and Forecast, By Condition, 2020-2032
6.2.2. Neuro Degenerative Diseases
6.2.2.1. Neuro Degenerative Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Epilepsy
6.2.3.1. Epilepsy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Stroke
6.2.4.1. Stroke Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Headache Disorders
6.2.5.1. Headache Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Sleep Disorders
6.2.6.1. Sleep Disorders Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.7. Other Diseases
6.2.7.1. Other Diseases Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Neurodiagnostics Market By End-Use
7.1. Introduction
7.2. Neurodiagnostics Revenue By End-Use
7.2.1. Neurodiagnostics Revenue (USD Billion) and Forecast, By End-Use, 2020-2032
7.2.2. Hospitals and Surgery Centers
7.2.2.1. Hospitals and Surgery Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Neurology Centers
7.2.3.1. Neurology Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Ambulatory Care Centers
7.2.4.1. Ambulatory Care Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Diagnostic Laboratories & Imaging Centers
7.2.5.1. Diagnostic Laboratories & Imaging Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Research Laboratories & Academic Institutes
7.2.6.1. Research Laboratories & Academic Institutes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Neurodiagnostics Market By Country
8.1. North America Neurodiagnostics Market Overview
8.2. U.S.
8.2.1. U.S. Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.S. Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
8.2.3. U.S. Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
8.3. Canada
8.3.1. Canada Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Canada Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
8.3.3. Canada Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Neurodiagnostics Market By Country
9.1. Europe Neurodiagnostics Market Overview
9.2. U.K.
9.2.1. U.K. Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. U.K. Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
9.2.3. U.K. Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.3. Germany
9.3.1. Germany Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Germany Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
9.3.3. Germany Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.4. France
9.4.1. France Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-203
9.4.2. France Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
9.4.3. France Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.5. Spain
9.5.1. Spain Neurodiagnostics Revenue (USD Billion) and Forecast Product, 2020-2032
9.5.2. Spain Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
9.5.3. Spain Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
9.6.3. Rest of Europe Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Neurodiagnostics Market By Country
10.1. Asia Pacific Neurodiagnostics Market Overview
10.2. China
10.2.1. China Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. China Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.2.3. China Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.3. Japan
10.3.1. Japan Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Japan Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.3.3. Japan Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.4. India
10.4.1. India Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. India Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.4.3. India Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.5. Australia
10.5.1. Australia Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.2. Australia Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.5.3. Australia Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.6. South Korea
10.6.1. South Korea Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.2. South Korea Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.6.3. South Korea Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
10.7.3. Rest of Asia-Pacific Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Neurodiagnostics Market By Country
11.1. Latin America Neurodiagnostics Market Overview
11.2. Brazil
11.2.1. Brazil Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. Brazil Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
11.2.3. Brazil Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.3. Mexico
11.3.1. Mexico Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. Mexico Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
11.3.3. Mexico Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
11.4.3. Rest of Latin America Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Neurodiagnostics Market By Country
12.1. Middle East & Africa Neurodiagnostics Market Overview
12.2. GCC
12.2.1. GCC Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.2. GCC Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
12.2.3. GCC Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.3. South Africa
12.3.1. South Africa Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.2. South Africa Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
12.3.3. South Africa Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Neurodiagnostics Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Neurodiagnostics Revenue (USD Billion) and Forecast By Condition, 2020-2032
12.4.3. Rest of Middle East & Africa Neurodiagnostics Revenue (USD Billion) and Forecast By End-Use, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Neurodiagnostics Market
13.1. Neurodiagnostics Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Landscape of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Neurodiagnostics Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Cadwell Laboratories
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Cadwell Laboratories 2022 Neurodiagnostics Business Regional Distribution
14.2. Blackrock NeuroMed
14.3. Compumedics
14.4. Delsys
14.5. Elmiko
14.6. LifeLines Neurodiagnostic Systems
14.7. Electrical Geodesic (EGI)
14.8. MEG International Services
14.9. Natus Medical
14.10. Motion Lab Systems
Frequently Asked Questions
How big is the neurodiagnostics market?
The neurodiagnostics market size was valued at USD 7.8 billion in 2022.
What is the CAGR of the global neurodiagnostics market from 2023 to 2032?
The CAGR of neurodiagnostics is 7.5% during the analysis period of 2023 to 2032.
Which are the key players in the neurodiagnostics market?
The key players operating in the global market are including Cadwell Laboratories, Blackrock NeuroMed, Compumedics, Delsys, Elmiko, LifeLines Neurodiagnostic Systems, Electrical Geodesic (EGI), MEG International Services, Natus Medical, and Motion Lab Systems.
Which region dominated the global neurodiagnostics market share?
North America held the dominating position in neurodiagnostics industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of neurodiagnostics during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global neurodiagnostics industry?
The current trends and dynamics in the neurodiagnostics industry include advancements in diagnostic technologies enhancing neurodiagnostic capabilities, increasing prevalence and awareness of neurological disorders, growing healthcare expenditure and infrastructure development, and ongoing research and development initiatives driving innovation in neurodiagnostics.
Which end-use held the maximum share in 2022?
The diagnostic laboratories & imaging centers end-use held the maximum share of the neurodiagnostics industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
